AstraZeneca puts leading COVID-19 vaccine trial on hold over safety concern

Reuters 09/09/2020

AstraZeneca Plc on Tuesday said it has paused a late-stage trial of one of the leading COVID-19 vaccine candidates after an unexplained illness in a study participant. “Our standard review process was triggered and we voluntarily paused…

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.